Dr. Kalyanam is the President of Sami-Sabinsa Group R&D. His research interests are synthetic methodology and chiral chemistry. He obtained his M.Sc. in Chemistry from the University of Madras and Ph.D. in Organic Chemistry from Baylor University (Texas). Upon completing his Ph.D., Dr. Kalyanam completed 2 years of postdoctoral studies focusing on organic synthesis procedures before returning to India. In India he worked for a number of reputable companies, IPCL, Ciba Geigy, and SPIC Pharma, to which he made major scientific contributions.
Dr. Kalyanam's primary responsibilities at Sabinsa include development of efficient and novel scientific routes for xenobiotics and intermediates as well as exploration of new business areas.